Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

253 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Extraneural spread of glioblastoma--report of two cases.
Templeton A, Hofer S, Töpfer M, Sommacal A, Fretz C, Cerny T, Gillessen S. Templeton A, et al. Among authors: cerny t. Onkologie. 2008 Apr;31(4):192-4. doi: 10.1159/000118627. Epub 2008 Mar 20. Onkologie. 2008. PMID: 18418021
Advances in the treatment of non-Hodgkin's lymphoma.
Cerny T, Gillessen S. Cerny T, et al. Ann Oncol. 2002;13 Suppl 4:211-6. doi: 10.1093/annonc/mdf662. Ann Oncol. 2002. PMID: 12401693 Free article. Review. No abstract available.
The proteasome, a new target for cancer therapy.
Gillessen S, Groettup M, Cerny T. Gillessen S, et al. Among authors: cerny t. Onkologie. 2002 Dec;25(6):534-9. doi: 10.1159/000068624. Onkologie. 2002. PMID: 12566898 Review.
[Mabthera for treatment of malignant lymphoma].
Cerny T, Hitz F, Gillessen S. Cerny T, et al. Ther Umsch. 2004 Jun;61(6):379-83. doi: 10.1024/0040-5930.61.6.379. Ther Umsch. 2004. PMID: 15253163 Review. German.
Thalidomide: from tragedy to promise.
von Moos R, Stolz R, Cerny T, Gillessen S. von Moos R, et al. Among authors: cerny t. Swiss Med Wkly. 2003 Feb 8;133(5-6):77-87. doi: 10.4414/smw.2003.09947. Swiss Med Wkly. 2003. PMID: 12644961 Free article. Review.
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma.
Waeckerle-Men Y, Uetz-von Allmen E, Fopp M, von Moos R, Böhme C, Schmid HP, Ackermann D, Cerny T, Ludewig B, Groettrup M, Gillessen S. Waeckerle-Men Y, et al. Among authors: cerny t. Cancer Immunol Immunother. 2006 Dec;55(12):1524-33. doi: 10.1007/s00262-006-0157-3. Epub 2006 Apr 13. Cancer Immunol Immunother. 2006. PMID: 16612599 Free PMC article. Clinical Trial.
253 results